{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:10:35Z","timestamp":1790820635745,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007543","name":"Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9","doi-asserted-by":"publisher","award":["HAP-2019-S003"],"award-info":[{"award-number":["HAP-2019-S003"]}],"id":[{"id":"10.13039\/501100007543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.celrep.2022.110825","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:14:06Z","timestamp":1652789646000},"page":"110825","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Combination of in\u00a0vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy"],"prefix":"10.1016","volume":"39","author":[{"given":"Rapha\u00eblle","family":"Delattre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Seurat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyrouz","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thu-Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9586-3014","authenticated-orcid":false,"given":"Baptiste","family":"Gaborieau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rokhaya","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-6689","authenticated-orcid":false,"given":"Nicolas","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-2299","authenticated-orcid":false,"given":"Jean-Damien","family":"Ricard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9mie","family":"Guedj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6875-5758","authenticated-orcid":false,"given":"Laurent","family":"Debarbieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2022.110825_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00029-12","article-title":"Bacteriophages \u03c6MR299-2 and \u03c6NH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.","volume":"3","author":"Alemayehu","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.celrep.2022.110825_bib2","doi-asserted-by":"crossref","first-page":"ofaa389","DOI":"10.1093\/ofid\/ofaa389","article-title":"Lessons learned from the first 10 consecutive cases of intravenous bacteriophage therapy to treat multidrug-resistant bacterial infections at a single center in the United States","volume":"7","author":"Aslam","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib3","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/IAI.66.3.912-922.1998","article-title":"Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice","volume":"66","author":"Bergeron","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.celrep.2022.110825_bib4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","article-title":"Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models","volume":"13","author":"Bergstrand","year":"2011","journal-title":"AAPS J."},{"key":"10.1016\/j.celrep.2022.110825_bib5","doi-asserted-by":"crossref","first-page":"12879","DOI":"10.1073\/pnas.0603038103","article-title":"How to become a uropathogen: comparative genomic analysis of extraintestinal pathogenic Escherichia coli strains","volume":"103","author":"Brzuszkiewicz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U\u00a0S\u00a0A"},{"key":"10.1016\/j.celrep.2022.110825_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2180-2-35","article-title":"Dynamics of success and failure in phage and antibiotic therapy in experimental infections","volume":"2","author":"Bull","year":"2002","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib7","doi-asserted-by":"crossref","first-page":"e1000253","DOI":"10.1371\/journal.ppat.1000253","article-title":"Quantitative models of in\u00a0vitro bacteriophage-host dynamics and their application to phage therapy","volume":"5","author":"Cairns","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2022.110825_bib8","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/649227","article-title":"Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection","volume":"201","author":"Carmody","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","article-title":"Ventilator-associated pneumonia","volume":"165","author":"Chastre","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.celrep.2022.110825_bib10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/cid\/ciz782","article-title":"Eradication of a multidrug-resistant, carbapenemase-producing Klebsiella pneumoniae isolate following oral and intra-rectal therapy with a custom made, lytic bacteriophage preparation","volume":"70","author":"Corbellino","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib11","doi-asserted-by":"crossref","first-page":"e00012-19","DOI":"10.1128\/MMBR.00012-19","article-title":"Pharmacologically aware phage therapy: pharmacodynamic and pharmacokinetic obstacles to phage antibacterial action in animal and human bodies","volume":"83","author":"Dabrowska","year":"2019","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.celrep.2022.110825_bib12","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1086\/651135","article-title":"Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections","volume":"201","author":"Debarbieux","year":"2010","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1208\/s12248-015-9745-5","article-title":"Nonlinear mixed-effect models for prostate-specific antigen kinetics and link with survival in the context of metastatic prostate cancer: a comparison by simulation of two-stage and joint approaches","volume":"17","author":"Desmee","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.celrep.2022.110825_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41579-019-0311-5","article-title":"Phage diversity, genomics and phylogeny","volume":"18","author":"Dion","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib15","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000000968","article-title":"Treatment of highly virulent extraintestinal pathogenic Escherichia coli pneumonia with bacteriophages","volume":"43","author":"Dufour","year":"2015","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.celrep.2022.110825_bib16","doi-asserted-by":"crossref","first-page":"e00379-19","DOI":"10.1128\/AAC.00379-19","article-title":"Phage therapy of pneumonia is not associated with an overstimulation of the inflammatory response compared to antibiotic treatment in mice","volume":"63","author":"Dufour","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.celrep.2022.110825_bib17","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijantimicag.2015.07.010","article-title":"Five-year trends for ventilator-associated pneumonia: correlation between microbiological findings and antimicrobial drug consumption","volume":"46","author":"Fihman","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.celrep.2022.110825_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.cmi.2019.12.008","article-title":"Acute bacterial or viral infection-What's the difference? A perspective from PKPD modellers","volume":"26","author":"Friberg","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.celrep.2022.110825_bib19","doi-asserted-by":"crossref","first-page":"e00066-18","DOI":"10.1128\/CMR.00066-18","article-title":"Phage therapy in the postantibiotic era","volume":"32","author":"Gordillo Altamirano","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.celrep.2022.110825_bib20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00134-012-2584-2","article-title":"Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia","volume":"38","author":"Hamet","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.celrep.2022.110825_bib21","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1128\/AAC.01596-13","article-title":"Predicting in\u00a0vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections","volume":"57","author":"Henry","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.celrep.2022.110825_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-1-60327-164-6_18","article-title":"Practical methods for determining phage growth parameters","volume":"501","author":"Hyman","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2022.110825_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(18)30482-1","article-title":"Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1\/2 trial","volume":"19","author":"Jault","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13054-017-1709-y","article-title":"Use of bacteriophages in the treatment of colistin-only-sensitive Pseudomonas aeruginosa septicaemia in a patient with acute kidney injury-a case report","volume":"21","author":"Jennes","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.celrep.2022.110825_bib25","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bjid.2013.06.004","article-title":"Clinical significance of different bacterial load of Mycoplasma pneumoniae in patients with Mycoplasma pneumoniae pneumonia","volume":"18","author":"Jiang","year":"2014","journal-title":"Braz. J. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib26","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1128\/JVI.76.11.5557-5564.2002","article-title":"Overcoming the phage replication threshold: a mathematical model with implications for phage therapy","volume":"76","author":"Kasman","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.celrep.2022.110825_bib27","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.chest.2016.11.026","article-title":"A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of Gram-Negative ventilator-associated pneumonia: IASIS trial","volume":"151","author":"Kollef","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.celrep.2022.110825_bib28","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","article-title":"Phage therapy: a renewed approach to combat antibiotic-resistant bacteria","volume":"25","author":"Kortright","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110825_bib29","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.csda.2004.07.002","article-title":"Maximum likelihood estimation in nonlinear mixed effects models","volume":"49","author":"Kuhn","year":"2005","journal-title":"Comput. Stat. Data Anal."},{"key":"10.1016\/j.celrep.2022.110825_bib30","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3201\/eid2504.180944","article-title":"Pneumonia-specific Escherichia coli with distinct phylogenetic and virulence profiles, France, 2012-2014","volume":"25","author":"La Combe","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1473-3099(20)30330-3","article-title":"Intravesical bacteriophages for treating urinary tract infections in patients undergoing transurethral resection of the prostate: a randomised, placebo-controlled, double-blind clinical trial","volume":"21","author":"Leitner","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtbi.2017.06.037","article-title":"Modeling the synergistic elimination of bacteria by phage and the innate immune system","volume":"429","author":"Leung","year":"2017","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.celrep.2022.110825_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.tim.2017.07.005","article-title":"Phagocytes, antibiotics, and self-limiting bacterial infections","volume":"25","author":"Levin","year":"2017","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib34","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejpb.2020.11.019","article-title":"Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation-A proof-of-principle study in a P. aeruginosa lung infection model","volume":"158","author":"Lin","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.celrep.2022.110825_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.chom.2020.06.002","article-title":"The spatial heterogeneity of the gut limits predation and fosters coexistence of bacteria and bacteriophages","volume":"28","author":"Lourenco","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110825_bib36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.clinthera.2020.07.014","article-title":"Phage therapy in the resistance era: where do we stand and where are we going?","volume":"42","author":"Luong","year":"2020","journal-title":"Clin. Ther."},{"key":"10.1016\/j.celrep.2022.110825_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/01902140701756562","article-title":"The role of the macrophage in lung disease mediated by bacteria","volume":"33","author":"Marriott","year":"2007","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.celrep.2022.110825_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/psp4.12372","article-title":"Model-informed drug discovery and development: current industry good practice and regulatory expectations and future perspectives","volume":"8","author":"Marshall","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.celrep.2022.110825_bib39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/1040841X.2020.1729695","article-title":"Phage therapy efficacy: a review of the last 10 years of preclinical studies","volume":"46","author":"Melo","year":"2020","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib40","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00134-012-2699-5","article-title":"Pathophysiology of Escherichia coli ventilator-associated pneumonia: implication of highly virulent extraintestinal pathogenic strains","volume":"38","author":"Messika","year":"2012","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.celrep.2022.110825_bib41","doi-asserted-by":"crossref","first-page":"e16963","DOI":"10.1371\/journal.pone.0016963","article-title":"Pulmonary bacteriophage therapy on Pseudomonas aeruginosa cystic fibrosis strains: first steps towards treatment and prevention","volume":"6","author":"Morello","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2022.110825_bib42","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1574-695X.2009.00580.x","article-title":"Use of stabilized luciferase-expressing plasmids to examine in\u00a0vivo-induced promoters in the Vibrio cholerae vaccine strain CVD 103-HgR","volume":"57","author":"Morin","year":"2009","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib43","first-page":"703","article-title":"Synergistic interaction between phage therapy and antibiotics clears Pseudomonas aeruginosa infection in endocarditis and reduces virulence","volume":"215","author":"Oechslin","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.celrep.2022.110825_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/jtbi.2000.2198","article-title":"Understanding bacteriophage therapy as a density-dependent kinetic process","volume":"208","author":"Payne","year":"2001","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.celrep.2022.110825_bib45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00003088-200342040-00002","article-title":"Pharmacokinetic principles of bacteriophage therapy","volume":"42","author":"Payne","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.celrep.2022.110825_bib46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrgastro.2015.97","article-title":"Modelling hepatitis C therapy--predicting effects of treatment","volume":"12","author":"Perelson","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.celrep.2022.110825_bib47","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.06330-11","article-title":"Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15","volume":"56","author":"Pouillot","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.celrep.2022.110825_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chom.2017.06.018","article-title":"Synergy between the host immune system and bacteriophage is essential for successful phage therapy against an acute respiratory pathogen","volume":"22","author":"Roach","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2022.110825_bib49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ebiom.2015.12.023","article-title":"Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh","volume":"4","author":"Sarker","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.celrep.2022.110825_bib50","doi-asserted-by":"crossref","first-page":"e00954-17","DOI":"10.1128\/AAC.00954-17","article-title":"Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant acinetobacter baumannii infection","volume":"61","author":"Schooley","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.celrep.2022.110825_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jtbi.2011.01.052","article-title":"Mathematical model of a three-stage innate immune response to a pneumococcal lung infection","volume":"276","author":"Smith","year":"2011","journal-title":"J.\u00a0Theor. Biol."},{"key":"10.1016\/j.celrep.2022.110825_bib52","first-page":"1111","article-title":"The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages","volume":"133","author":"Smith","year":"1987","journal-title":"J.\u00a0Gen. Microbiol."},{"key":"10.1016\/j.celrep.2022.110825_bib53","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1038\/s41598-019-39773-3","article-title":"Environmental structure drives resistance to phages and antibiotics during phage therapy and to invading lysogens during colonisation","volume":"9","author":"Sousa","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2022.110825_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5193(03)00262-5","article-title":"Models of phage growth and their applicability to phage therapy","volume":"227","author":"Weld","year":"2004","journal-title":"J.\u00a0Theor. Biol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722005964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124722005964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:40:42Z","timestamp":1761910842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124722005964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2211124722005964"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110825","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.04.433924","asserted-by":"object"}]},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of in\u00a0vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2022.110825","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"110825"}}